Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05915065 · ClinicalTrials.gov registry record · NA

VR to Evaluate Phantom Limb Pain

A NA study of Amputation and Phantom Limb Pain, sponsored by Shirley Ryan AbilityLab.

Active
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT05915065 is a NA study of Amputation and Phantom Limb Pain that is active but no longer recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 48 participants, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05915065, a NA study of Amputation and Phantom Limb Pain, is active but no longer recruiting, sponsored by Shirley Ryan AbilityLab.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to develop a virtual rehabilitation system that can be used to effectively treat Phantom Limb Pain (PLP) within the research setting and for at-home use by individuals with upper and lower extremity amputation. We hypothesize that the system will improve PLP for individuals with upper or lower extremity amputation, as measured through with various outcome measures and questionnaires.

Interventions

  • DEVICE Coapt Phantom Limb Pain Management System

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2020-10-01
Est. Completion 2025-09-30
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT05915065

The ClinicalTrials.gov registry entry for NCT05915065 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 132-participant average among 65 other Amputation trials with a reported enrollment target (64% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which Coapt Phantom Limb Pain Management System is the first listed.

NCT05915065 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05915065 about?

NCT05915065 is a clinical study titled "VR to Evaluate Phantom Limb Pain". The objective of this study is to develop a virtual rehabilitation system that can be used to effectively treat Phantom Limb Pain (PLP) within the research setting and for at-home use by individuals with upper and lower extremity amputation. We hypothesize that the system will improve PLP for indiv...

What is the current status of trial NCT05915065?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2020-10-01. Estimated completion is 2025-09-30.

What conditions does trial NCT05915065 study?

This clinical trial studies the following conditions: Amputation, Phantom Limb Pain, Upper Limb Amputation Below Elbow (Injury), Phantom Pain Following Amputation of Lower Limb, Phantom Pain.

What interventions are being tested in trial NCT05915065?

The interventions under investigation include: Coapt Phantom Limb Pain Management System (DEVICE).

Who is sponsoring clinical trial NCT05915065?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05915065 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.